Australian Pharma Stock News

As Australian shares prepare for a modest rise, the local market is closely watching economic indicators such as job advertisements and building approvals, alongside international developments like U.S.-Iran peace talks. For investors considering smaller or newer companies, penny stocks—despite their somewhat outdated name—remain an intriguing area of investment. These stocks can offer surprising value and growth potential when backed by strong financials, making them worth considering for...

In May 2026, InComm Payments announced a partnership with Zip Co to bring installment buying to the gift card category, allowing eligible US shoppers to purchase and split payments for leading retail, entertainment, dining, and travel gift cards directly within the Zip app. This move extends Zip’s flexible payment model into the large gift card market, potentially deepening customer engagement by keeping the entire selection and checkout process inside its platform. Next, we’ll examine how...

In May 2026, 4DMedical held a special call to present on the clinical use of its CT:VQ technology, highlighting how the platform may be applied in real-world respiratory imaging. This focused discussion on CT:VQ’s clinical role adds fresh context to earlier expectations that the technology could open access to a large VQ imaging market. We’ll now examine how this CT:VQ clinical-use call may influence 4DMedical’s investment narrative built around technology adoption and earnings...

James Hardie Industries (ASX:JHX) has put fresh numbers on the table with fourth quarter and full year results alongside new sales guidance for fiscal 2027, giving investors updated data to reassess the stock. See our latest analysis for James Hardie Industries. At a share price of A$32.27, James Hardie Industries has seen a 9.8% 7 day share price return and 9.8% 30 day share price return, but the 1 year total shareholder return is down 10.2%. This suggests recent momentum has picked up after...

Recent price performance and business snapshot Greatland Resources (ASX:GGP) has drawn fresh investor attention after a recent move in the share price, with the stock last closing at A$13.82 and sitting on a year to date return of 30.87%. The company operates gold and copper assets in Western Australia, including the Telfer mine and the Havieron brownfield development project, and reports revenue of A$1,918.14 and net income of A$645.06. See our latest analysis for Greatland Resources. That...

In May 2026, Westpac Banking Corporation was ordered by the Federal Court to pay A$26.00 million in civil penalties after failing over nearly six years to respond within the legal timeframe to more than 200 online financial hardship requests from customers across Westpac, St.George, BankSA and Bank of Melbourne. The court highlighted that Westpac’s failures led to extra harm, including adverse credit listings and the sale of some customers’ debts to third-party collectors, and rejected...

Life360 share repurchase sets the stage for reassessing the stock Life360 (ASX:360) has announced a share repurchase program of up to A$225 million, aimed at offsetting dilution from stock based instruments. This places capital allocation and shareholder value front and center for investors. See our latest analysis for Life360. Life360's share price has moved sharply around the buyback news, with a 1 day share price return of 5.38% and 7 day return of 7.38%. Year to date the share price is...

IperionX Limited recently completed site acceptance and commissioning of a 300-ton six-axis SACMI powder metallurgy press at its Titanium Manufacturing Campus in South Boston, Virginia, materially expanding its U.S. titanium component production capabilities. This new press, to be integrated with additional HSPT sintering and forging furnaces under the U.S. Government-supported IBAS program, positions IperionX to support a wider range of complex, high-volume titanium manufacturing...

As the Australian market navigates a cautious start to the week, with modest gains and an eye on economic indicators and international developments, investors are closely monitoring potential opportunities. Penny stocks, despite their somewhat outdated moniker, remain an intriguing investment area for those seeking growth in smaller or newer companies. These stocks can offer significant value when backed by robust financials, and we'll explore three such examples that may present promising...

We wouldn't blame Web Travel Group Limited ( ASX:WEB ) shareholders if they were a little worried about the fact that...

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

Biome Australia Limited ( ASX:BIO ), might not be a large cap stock, but it received a lot of attention from a...

As the Australian market rebounds from a significant $45 billion loss, bolstered by positive developments on Wall Street and potential geopolitical resolutions, investors are keenly assessing opportunities in dividend stocks. In such a dynamic environment, selecting stocks with strong fundamentals and consistent dividend payouts can offer stability and income potential amidst market fluctuations.

As Australian shares rebound from a significant market downturn, driven by global events and domestic fiscal policies, investors are keenly observing the landscape for opportunities. In this environment, growth companies with high insider ownership can be particularly appealing due to their potential for alignment of interests between management and shareholders.

The Australian share market is showing signs of recovery following a significant $45 billion downturn, with a modest 0.7% rise anticipated as optimism grows from potential geopolitical resolutions and Wall Street's record highs. In this fluctuating environment, identifying undervalued stocks can be crucial for investors seeking to capitalize on market inefficiencies, and this article will explore three such opportunities on the ASX, including Navigator Global Investments.

As the Australian market rebounds from a recent significant downturn, driven by global geopolitical developments and local economic policy discussions, investors are keenly observing small-cap stocks for potential opportunities. In this dynamic environment, identifying promising companies like Cobram Estate Olives and other emerging small caps can be crucial for those looking to capitalize on growth prospects amidst fluctuating market conditions.

Australian shares are showing signs of recovery after a significant market dip, with a modest increase driven by positive developments overseas and ongoing domestic budgetary discussions. Penny stocks, though often considered niche investments, continue to attract attention for their potential to offer growth opportunities at lower price points. In this context, we explore three penny stocks on the ASX that stand out due to their strong fundamentals and promising prospects.

For investors wondering whether Mineral Resources at A$73.47 is starting to look expensive or if the recent enthusiasm still leaves room for value, this article breaks down what the current price might be implying. The stock has recently posted returns of 5.5% over 7 days, 15.3% over 30 days, 32.5% year to date and 231.1% over the past year, which has put valuation firmly in the spotlight for many investors. Recent news coverage has focused on Mineral Resources in the context of broader...

AMP (ASX:AMP) has drawn fresh attention after appointing Jackie Cleary as Chief Financial Officer, a role that shapes financial policy, reporting, and capital decisions that many investors watch closely. See our latest analysis for AMP. Recent trading reflects a mixed picture, with AMP's share price at A$1.595 and a 30 day share price return of 9.25% and 90 day share price return of 22.69%. The year to date share price return is down 12.84% and the 1 year total shareholder return is...

4DMedical special call puts CT:VQ clinical use in focus 4DMedical (ASX:4DX) is drawing fresh attention after scheduling a special call to present on the clinical use of its CT:VQ non contrast post processing technology, spotlighting how this lung imaging software might fit into everyday healthcare workflows. See our latest analysis for 4DMedical. The A$3.97 share price has moved sharply around this news, with an 18.86% 1 day share price return and 9.67% 7 day share price return, in contrast...

Qantas’ new bond issue and what it might mean for ASX:QAN Qantas Airways (ASX:QAN) has launched a A$500 million fixed income offering, issuing 6.659% senior unsecured notes due May 19, 2036. This move could influence how investors think about its capital structure and liquidity. See our latest analysis for Qantas Airways. The recent A$500 million bond issue lands as Qantas’ share price trades at A$9.44, with a 1 month share price return of 12.25% after earlier weakness that left the year to...

Beach Energy (ASX:BPT) continues to make royalty payments to Newport Exploration linked to its Cooper Basin production. These payments reflect Newport Exploration's overriding royalty interest over certain Beach Energy operated permits. The arrangement highlights the ongoing cash flow generated from Beach Energy's Cooper Basin assets. Beach Energy, trading at A$1.08, has seen its share price fall 4.4% over the past week and 8.1% over the past month. Over longer periods, the stock is down...

If you are wondering whether Macquarie Group at around A$238.55 is offering good value or asking too much, the starting point is to get clear on what the current price is really implying. The stock is roughly flat over the past week with a 0.7% decline, while returns of 1.5% over 30 days, 17.1% year to date and 14.9% over 1 year give useful context before looking at any valuation metrics. Recent coverage has focused on Macquarie Group's position in capital markets and its role across asset...

Potential labor action at BHP Group (ASX:BHP)'s Western Australia iron ore export hub, along with a recent downgrade to Neutral, is putting the stock under closer scrutiny as a new CEO prepares to take charge. See our latest analysis for BHP Group. Despite concerns around China demand, macro risks and potential labor action, the stock has shown firm momentum, with a 30 day share price return of 15.99% and a 1 year total shareholder return of 69.69%. This suggests that recent optimism has...